Literature DB >> 16293969

Evaluation of enzymes involved in proteoglycan degradation in the wall of abdominal aortic aneurysms.

Radosław Kowalewski1, Krzysztof Sobolewski, Andrzej Małkowski, Małgorzata Wolańska, Marek Gacko.   

Abstract

The abdominal aortic aneurysm (AAA) wall represents an extreme example of arterial remodeling with disturbed elastin, collagen and proteoglycan metabolism. The aim of this study was to evaluate enzymes involved in the degradation of glycosaminoglycan chains and core proteins of proteoglycans in the AAA wall. The study material consisted of wall samples from 10 AAA. Fragments of 5 normal abdominal aortas from organ donors were used as a control. The activity of endoglycosidases, exoglycosidases and sulfatases was measured using colorimetric methods. To assess matrix metalloproteinases (MMPs), Western blot and zymography were performed. The activity of endoglycosidase degrading chondroitin-4-sulfate was lower in the AAA wall. Endoglycosidase degrading heparan sulfate and dermatan sulfate, arylosulfatase B, as well as all the exoglycosidases assessed demonstrated higher activities in the AAA wall. Furthermore, increased expression of MMP1, MMP2 and MMP9 was also shown in the AAA wall. Zymography revealed decreased activity of pro-MMP2 and presence of pro-MMP9 in the AAA wall compared to the wall of normal aorta. Extensive changes in the activity of glycosaminoglycan-degrading enzymes and MMPs may influence the organization of the extracellular matrix network and lead to previously demonstrated changes in the proteoglycan and glycosaminoglycan content in the AAA wall. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293969     DOI: 10.1159/000089790

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  8 in total

1.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

Review 2.  Circulating markers of abdominal aortic aneurysm presence and progression.

Authors:  Jonathan Golledge; Philip S Tsao; Ronald L Dalman; Paul E Norman
Journal:  Circulation       Date:  2008-12-02       Impact factor: 29.690

3.  Alterations in aortic cellular constituents during thoracic aortic aneurysm development: myofibroblast-mediated vascular remodeling.

Authors:  Jeffrey A Jones; Christy Beck; John R Barbour; Jouzas A Zavadzkas; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

4.  On the epigenetics of vascular regulation and disease.

Authors:  Christina Schleithoff; Susanne Voelter-Mahlknecht; Indra Navina Dahmke; Ulrich Mahlknecht
Journal:  Clin Epigenetics       Date:  2012-05-23       Impact factor: 6.551

5.  Screening for abdominal aortic aneurysm during transthoracic echocardiography in patients with significant coronary artery disease.

Authors:  Sung Ho Lee; Sung-A Chang; Shin Yi Jang; Sang-Chol Lee; Young Bin Song; Seung Woo Park; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Jae K Oh; Duk-Kyung Kim
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

6.  ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm.

Authors:  Kim E Kortekaas; C Arnoud Meijer; Jan Willem Hinnen; Ronald L Dalman; Baohui Xu; Jaap F Hamming; Jan H Lindeman
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.

Authors:  Khira Othmani Mecif; Souhila Aouichat Bouguerra; Yasmina Benazzoug
Journal:  J Nutr Metab       Date:  2017-01-04

8.  The elevated expression of TLR4 and MMP9 in human abdominal aortic aneurysm tissues and its implication.

Authors:  Tan Li; Xintong Li; Xiaozheng Liu; Jun Yang; Chunyan Ma
Journal:  BMC Cardiovasc Disord       Date:  2021-08-04       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.